BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 27
• 28

• Deals

  Winner Medical Group Stockholders Vote to Approve Merger

  December 7, 2012

   · 

  2 min read
• Drug Development

  Stemline Therapeutics, Inc. Announces Presentations of SL-401 Updated Clinical Trial Results in Acute Myeloid Leukemia (AML) and Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) and SL-101 Preclinical Efficacy Data Against Hodgkin’s Lymphoma at the 54

  December 7, 2012

   · 

  5 min read
• IntelGenx Corp. Grants Stock Options

  December 7, 2012

   · 

  1 min read
• Drug Development

  Eisai Inc. Release: Phase III Study Results of Halaven® (eribulin mesylate) Injection in Metastatic Breast Cancer Presented at SABCS

  December 7, 2012

   · 

  7 min read
• Pharm Country

  Blue Belt Technologies, Inc. Announces Golden Jubilee National Hospital Completes Initial NavioPFS Unicondylar Knee Replacement Surgery

  December 7, 2012

   · 

  2 min read
• Biotech Beach

  CombiMatrix Corporation Release: National Institutes of Health (NIH) Studies in The New England Journal of Medicine Favor Chromosomal Microarray Analysis Over Standard Karyotyping for Genetic Analysis

  December 7, 2012

   · 

  1 min read
• Policy

  Abiomed Release: FDA 515i Reclassification Panel Recommends Class III Status for Temporary Ventricular Support Devices in the Non-Roller Type Cardiopulmonary Bypass Blood Pumps Category

  December 7, 2012

   · 

  1 min read
• Business

  Analogic Corporation Announces Financial Results for the First Quarter Ended October 31, 2012 and Declares Quarterly Cash Dividend

  December 7, 2012

   · 

  1 min read
• Drug Development

  Novavax, Inc.’ Phase I RSV Vaccine Data Published in Vaccine

  December 7, 2012

   · 

  1 min read
• Drug Development

  FDA Grants Orphan Drug Designation to Biodel Inc.l’s Glucagon for Prevention of Hypoglycemia in Congenital Hyperinsulinism Population

  December 7, 2012

   · 

  1 min read